{"id": "1357592293189033984", "creation": 1612510200.0, "user_id": "1211892441529241601", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 2, "quote_count": 1}}, "text": "Cooperation between #China's #Sinopharm and Group 42, Abu Dhabi-based #AI&amp;cloud computing company, in clinical trials for #COVID19 #vaccine has strengthened bilateral trust and partnership, said Tariq Bin Hendi, director general and CEO of the Abu Dhabi Investment Office or ADIO. https://t.co/5cTcttjdwB", "first_save": 1634559108.199414, "hashtags": ["#CHINA", "#SINOPHARM", "#AI", "#COVID19", "#VACCINE"]}